Literature DB >> 2441217

Interferons in cancer therapy: a reappraisal.

F R Balkwill, J F Smyth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2441217     DOI： 10.1016/s0140-6736(87)90901-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  PKR, a p53 target gene, plays a crucial role in the tumor-suppressor function of p53.

Authors:  Cheol-Hee Yoon; Eun-Soo Lee; Dae-Seog Lim; Yong-Soo Bae
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-24       Impact factor: 11.205

2.  Intratumoural and intraventricular human lymphoblastoid alpha interferon (HLBI) for treatment of glioblastoma multiforme.

Authors:  R Martínez; J Vaquero; J Ramiro; F García Salazar; S De Oya
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

3.  Phase I study of escalating dose mitoxantrone in combination with alpha-2-interferon in patients with advanced solid tumors.

Authors:  G Gasparini; S Dal Fior; F Pozza; G A Panizzoni; S Favretto; D D Von Hoff
Journal:  Invest New Drugs       Date:  1991-08       Impact factor: 3.850

4.  Circulating white blood cell count and measures of adipose tissue inflammation predict higher 24-h energy expenditure.

Authors:  Jianying He; Duc Son Le; Xiaoyuan Xu; Michael Scalise; Anthony W Ferrante; Jonathan Krakoff
Journal:  Eur J Endocrinol       Date:  2009-11-24       Impact factor: 6.664

Review 5.  Immunotherapy in small cell lung cancer: one step at a time: a narrative review.

Authors:  Daphne W Dumoulin; Anne-Marie C Dingemans; Joachim G J V Aerts; Jordi Remon; Dirk K M De Ruysscher; Lizza E L Hendriks
Journal:  Transl Lung Cancer Res       Date:  2021-06

Review 6.  The role of interferons in the treatment of malignant neoplasms.

Authors:  J R Murren; A C Buzaid
Journal:  Yale J Biol Med       Date:  1989 May-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.